Cuba’s healthcare system is genuinely impressive in some ways and deeply strained in others. The country produces health outcomes that rival wealthy nations, with an infant mortality rate of 7 deaths per 1,000 live births and life expectancy around 73 years overall, despite spending a fraction of what most developed countries invest. But those headline numbers exist alongside crumbling hospital infrastructure, chronic medicine shortages, and a two-tier system that treats tourists very differently from locals.
How Cuba’s Primary Care Model Works
Cuba’s system is built around prevention rather than treatment, and its structure is unlike anything in most countries. The foundation is the family doctor-and-nurse team. Each team is responsible for just 20 to 40 families. They live in apartments above their government-built clinics, making them available around the clock. These teams make home visits to every family at least once a year, assess people with chronic illnesses every three months, and perform a comprehensive health evaluation on each person twice a year.
Above these neighborhood offices sit community polyclinics, each serving 30,000 to 60,000 people. These function as both treatment centers and training facilities for medical and nursing students. At the top are hospitals and specialty centers. The idea is that most problems get caught early at the neighborhood level, reducing the burden on hospitals. This layered structure is the main reason Cuba’s outcomes punch above its economic weight.
Cuba also has far more doctors per person than almost any country on Earth: 9.5 physicians per 1,000 people, compared to 3.4 per 1,000 across OECD nations. That nearly threefold advantage means patients have unusually direct access to a doctor who knows their health history personally.
Health Outcomes Compared to Wealthier Nations
The numbers that draw international attention are real. Cuba’s infant mortality rate of 7 per 1,000 live births is comparable to the United States and better than many Latin American neighbors. Life expectancy sits at about 76.5 years for women and 71.1 years for men, according to WHO data from 2021. Those figures have actually declined somewhat over the past two decades (women’s life expectancy dropped about 2.5 years since 2000, men’s by about 3.5 years), reflecting growing economic pressures on the system.
These outcomes are achieved at a cost per capita that is a small fraction of what the U.S. or Europe spends. The system’s emphasis on early detection and community-level prevention keeps many conditions from escalating into expensive emergencies. Vaccination rates are high, and infectious disease surveillance is tightly integrated into the neighborhood clinic structure.
Cuba’s Biotech Sector
One of the more surprising aspects of Cuban healthcare is its homegrown biotechnology industry. Cuba developed CIMAvax-EGF, an immunotherapy for advanced non-small cell lung cancer, and it’s now approved for use across the island. In a large real-world trial involving 741 patients treated at 119 polyclinics and 24 hospitals, patients who completed the initial vaccination course had a median survival of about 10 months. Those who responded well to frontline treatment before vaccination saw median survival reach 12 months. Side effects were mostly mild: injection site reactions, fever, and headaches.
This isn’t a cure, but for patients with advanced cancer who have exhausted other treatment options, it represents a meaningful extension of life and improved quality of life over time. Cuba has also developed its own COVID-19 vaccines and several other biologics, making it one of the few low-income countries with a significant pharmaceutical export capacity.
The Gap Between the Model and Daily Reality
The system’s design is widely admired, but the daily experience of Cuban patients often tells a different story. Hospital infrastructure has deteriorated significantly. The Pan American Health Organization has reported that 385 health facilities sustained various levels of damage from recent disasters, while seven provinces face severe water shortages, with some areas seeing 80% or more of their water supply disrupted. Repeated failures of the national electrical grid compound the problem, leaving hospitals vulnerable to power outages during emergencies.
Medicine shortages are perhaps the most immediate concern for ordinary Cubans. There is a documented shortage of reagents and laboratory supplies for diagnostics, antibiotics, and other essential drugs. Pharmacies frequently lack basic medications. If you’re a Cuban who takes a daily medication for a chronic condition, finding a steady supply can be a real challenge. The U.S. trade embargo has raised the cost of medical supplies and food for decades, making it harder and more expensive to import equipment, spare parts, and pharmaceuticals.
Two Different Systems: Locals vs. Tourists
Cuba operates a parallel healthcare network called Servimed that is completely separate from the public system used by Cuban citizens. More than 40 specialized Servimed centers across the country serve foreign visitors, offering high-tech services and specialized care across different branches of medicine. Tourists don’t need appointments, and hotels can arrange transfers to these facilities quickly.
The contrast with neighborhood clinics is stark. Servimed centers are better equipped and better supplied. Meanwhile, the pharmacies available to Cubans often lack a wide range of medicines. This dual system is a practical reality that shapes how you should interpret any claim about Cuban healthcare quality: the answer depends heavily on who is receiving the care.
Medical Diplomacy Abroad
Cuba’s healthcare influence extends well beyond its borders. An estimated 325,000 Cuban healthcare workers have served abroad as of 2020, making it one of the largest medical personnel export programs in history. Cuban doctors and nurses have worked across South America, Africa, Southeast Asia, and the Pacific, often in remote or underserved areas where local healthcare infrastructure is minimal.
This program serves dual purposes. It generates significant revenue for the Cuban government and builds diplomatic relationships, while also providing genuine medical care to communities that would otherwise go without. The program has drawn criticism for the working conditions imposed on participating doctors, some of whom report low pay and restricted movement. But the scale and reach of the effort are undeniable, and many recipient countries credit Cuban medical teams with measurable improvements in local health outcomes.
What “Good Healthcare” Actually Means in Cuba
Cuba’s healthcare system is genuinely good at prevention, early detection, and community-level care. Its doctor-to-patient ratio is extraordinary, its primary care model is studied worldwide, and its biotech achievements are remarkable for a country of its size and income level. If you measure a system by population-level outcomes like infant mortality and life expectancy, Cuba performs far better than its GDP would predict.
But if you measure healthcare by whether a patient can reliably get the medication they need, whether hospitals have functioning equipment and clean water, or whether diagnostic labs have the supplies to run tests, Cuba’s system is under severe strain. The economic pressures that have worsened over the past decade, including the ongoing U.S. embargo, pandemic-related disruptions, and energy crises, have widened the gap between the system’s elegant design and the care patients actually receive. Cuba has good healthcare in concept and structure. Whether it delivers good healthcare on any given day depends on which facility you walk into and what you need when you get there.